| abstract |
The present invention addresses the issue of providing a cell pharmaceutical composition capable of maintaining a cell state well and a high survival rate over the long term.nThis cell pharmaceutical composition contains cells (A) and a cell suspension solution (B). The cell suspension solution (B) is an electrolytic solution that includes Na + , Cl – , K + , and Ca 2+ as electrolytes, does not include carbohydrates, and is isotonic. The cell suspension solution (B) may further include at least one type of electrolyte selected from the group consisting of CH 3 COO – , HCO 3 n – , citrate ions, and lactate ions. |